Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum (ER) stress signaling refers to the cellular response mechanisms activated when the ER, a key organelle responsible for protein folding and processing, is overwhelmed by an accumulation of unfolded or misfolded proteins. This condition disrupts ER homeostasis and triggers adaptive signaling pathways collectively known as the unfolded protein response (UPR). The UPR aims initially to restore homeostasis by reducing protein synthesis, increasing chaperone production, and promoting misfolded protein degradation. If these measures fail, prolonged activation leads to apoptosis. Key pathways include IRE1/XBP1, PERK/eIF2α/ATF4, and ATF6. ER stress is implicated in various diseases, and targeting UPR components has potential therapeutic value.
Modulation of specific UPR arms to restore proteostasis or induce apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic Reticulum Stress Signaling.